Advertisement
UK markets closed

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • FTSE 250

    19,719.37
    -80.35 (-0.41%)
     

  • AIM

    754.05
    -0.82 (-0.11%)
     

  • GBP/EUR

    1.1632
    +0.0004 (+0.03%)
     

  • GBP/USD

    1.2431
    -0.0021 (-0.17%)
     

  • Bitcoin GBP

    51,979.61
    -1,552.16 (-2.90%)
     

  • CMC Crypto 200

    1,400.69
    -23.41 (-1.64%)
     

  • S&P 500

    5,054.12
    -16.43 (-0.32%)
     

  • DOW

    38,346.79
    -156.90 (-0.41%)
     

  • CRUDE OIL

    82.86
    -0.50 (-0.60%)
     

  • GOLD FUTURES

    2,340.20
    -1.90 (-0.08%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • CAC 40

    8,091.86
    -13.92 (-0.17%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·56-min read
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript

Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Form 10-K and 10-Q. To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's 2022 results and business performance, recent events, and priorities going forward. Joining Richard and Eli on the call today is Sven Dethlefs, head of North America business, who will be available during the question-and-answer session that will follow the presentation.

Continue reading